Filing Flows › Viemed Healthcare (VMD) › Q2 2026 › vs Q2 2025
Viemed Healthcare (VMD) Q2 2026 vs Q2 2025 (year over year)
Viemed Healthcare's revenue rose $15.0M (+24%) from $63.1M in Q2 2025 to $78.1M in Q2 2026. Gross margin 57.7% against 58.3% (-0.6 pts).
Viemed Healthcare, Q2 2026: revenue $78.1M (+24% year over year), operating margin 5.7%, net earnings $2.8M, operating cash flow $15.9M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 57.7% | 58.3% | -0.6 pts |
| Operating margin | 5.7% | 8.1% | -2.4 pts |
| Net margin | 3.5% | 5.0% | -1.5 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $78.1M | $63.1M | $15.0M | +24% |
| Gross profit | $45.0M | $36.7M | $8.3M | +23% |
| Cost of revenue | $33.0M | $26.3M | $6.7M | +26% |
| Operating profit | $4.5M | $5.1M | −$634K | -12% |
| Operating expenses | $40.6M | $31.6M | $9.0M | +28% |
| Pre-tax earnings | $4.1M | $5.0M | −$912K | -18% |
| Other expense, net | $410K | $132K | $278K | +211% |
| Research & development | $504K | $847K | −$343K | -40% |
| SG&A | $37.1M | $28.8M | $8.3M | +29% |
| Other operating costs | $3.0M | $2.0M | $965K | +49% |
| Net earnings | $2.8M | $3.2M | −$393K | -12% |
| Minority interests | $136K | $93K | $43K | +46% |
| Income tax | $1.2M | $1.7M | −$562K | -33% |
| Depreciation & amortization | $7.5M | $6.9M | $629K | +9% |
| Share-based compensation | $2.0M | $2.3M | −$309K | -13% |
| Working capital & other | $3.6M | −$135K | $3.7M | — |
| Operating cash flow | $15.9M | $12.3M | $3.6M | +30% |
Questions
How much did Viemed Healthcare's revenue grow year over year in Q2 2026?
Viemed Healthcare's revenue rose $15.0M (+24%) from $63.1M in Q2 2025 to $78.1M in Q2 2026. Gross margin 57.7% against 58.3% (-0.6 pts).